Repeat-Dose Study of Bavituximab in Patients With Chronic Hepatitis C
Clinical trial NCT00343525 · COMPLETED
Trial details
- NCT number
- NCT00343525
- Sponsor
- Peregrine Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2007-01-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.